News

Chinas National Medical Products Administration approved Lilly’s shot for long-term weight management on Friday ... regulator initially cleared the drug for diabetes. The shares gained ...
Eli Lilly announced on its WeChat account Friday that it has won approval from Chinese regulators to sell tirzepatide for weight loss in the country. Tirzepatide is the active ingredient in ...
Tirzepatide is the active ingredient in the U.S. firm's diabetes drug Mounjaro, also approved in China, and weight-loss drug Zepbound. Eli Lilly and Novo Nordisk are racing to ...
the U.S. firm’s weight-loss drug with the same active ingredient, will be approved in China this year or in the first half of 2025. Both Eli Lilly and Novo are racing to increase ...
Novo Nordisk said Tuesday that its Wegovy weight loss ... s Ozempic diabetes drug was approved in 2021 and saw sales in the greater China region double last year. Novo Nordisk and ...
On Friday, Chinas National Medical Products Administration (NMPA) approved Eli Lilly And Co (NYSE ... Mounjaro for diabetes and Zepbound for weight loss. Related: Chinese Generic Ozempic ...
Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk NOVO.B1.91%increase; green up pointing triangle to begin selling it in the world’s second ...